期刊名称：PHARMACOLOGICAL REVIEWS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Papers published in Pharmacological Reviews are generally invited by the Editor afterconsideration of recommendations from the Associate Editors. Others who have aninterest in writing for Pharmacological Reviews are encouraged to send proposals tothe Editor. The proposal should include a detailed outline of the proposed article and abrief curriculum vitae. Articles in Pharmacological Reviews deal mainly with the current status of the subject under review. They are to be written clearly and concisely and should be intelligible to nonspecialists, with definitions of unfamiliar technical terms and explanations of difficult or controversial points included. At the same time, the review is to be sufficiently precise and detailed to command the attention and respect of experts in the field. Selective rather than exhaustive coverage of the literature is requested. Previous reviews of the subject and of related fields should be cited. Authors are asked to be critical of methods, results, and conclusions and to challenge accepted concepts where warranted. Conflicting points of view are to bepresented objectively in good perspective. Deficiencies in the field may be pointed out and avenues for further work may be indicated. The usual length ranges between 12 and 50 printed pages, corresponding to about 40 to 150 manuscript pages. Diagrams, tables, and illustrations should be included to bring out new concepts and important relationships.
Instructions to Authors
Submission of Manuscripts
Submit three (3) collated copies of each manuscript (including illustrations) to: Dr. Darrell R. Abernethy, Editor, Pharmacological Reviews, NIA, Gerontology Research Center, 5600 Nathan Shock Drive, Baltimore, MD 21224; telephone: (410) 558-8611; fax: (410) 558-8318; e-mail: abernethyd@grc.nia.nih.gov
A completed copy of the Authorship Responsibility, Financial Disclosure and CopyrightTransfer form signed by all authors should be included with the manuscript at the timeof submission [Fill-In PDF Version of Authorship Responsibility, Financial Disclosure and Copyright Transfer Form]. Submission of a manuscript amounts to assurance that it has received proper clearance from the author's company or institution, that it has not been copyrighted, published, or accpeted for publication elsewhere, that it is not currently being considered for publication elsewhere, and that it will not be submitted elsewhere while under consideration by Pharmacological Reviews. The corresponding author is responsible for obtaining permission from the copyright owner to reproduce or modify figures and tables and to reproduce text (in whole or in part) from previous publications; permissions must allow electronic reproduction as well as print. A permissions request form is available from the editorial office. The signed permissions must be submitted with the manuscript and be identified as to the relevant item in the manuscript (e.g., "permissions for Fig. 1"). In addition, a statement indicating that the material is being reprinted with permission must be included in the relevant figure legend or table footnote of the manuscript. Reprinted text must be enclosed in quotation marks, and the permission statement must be included as running text or indicated parenthetically.
Manuscripts must be in English, typewritten using only Ariel or Times Roman font, and double spaced throughout, includingreferences, tables, and figure legends, using only one side of 8-1/2 by 11 inch (ca. 216by 280 mm) paper, with at least 1 inch (25 mm) margins. Three (3) sets of figures should be submitted including one original set (see Figures). Three (3) copies of papers reporting any potentially overlapping earlier work (including relevant "in press" papers) must be included. Rejected manuscripts, figures, and original drawings will not be returned unless specifically requested at the time of submission.
Organization of the Manuscript
Manuscripts should contain the following sections in the order listed. Each section should begin on a new page and all pages should be numbered consecutively.
1. Title page. This should contain the complete title of the article, the names of all authors, and the laboratory of origin. Financial support for the research should be indicated as an unnumbered footnote to the title and included with other footnotes on a separate page following the References section.
2. Running title page. The running title page should contain the following:
a) A running title, which conveys the sense of the full title (not to exceed 60 characters,including spaces and punctuation). Commonly used abbreviations (e.g., "ATP," "ACh,"etc.) may be used.
b) The name, address, telephone and fax numbers, and e-mail address of the corresponding author. The e-mail address will also be used as a hypertext link in the on-line version of the paper.
c) A list of nonstandard abbreviations used in the paper. Standard abbreviations are those listed in the Instructions to Authors of the Journal of Biological Chemistry, 272:1-4 (1997).
3. Abstract. Effective with the March 2000 issue, Pharmacological Reviews articles will include abstracts of no more than 250 words. A word is one or more characters bounded by white space. The abstract should be intelligible to the general reader without reference to text. Reference citations are not permitted in abstracts, and nonstandard abbreviations should not be included.
4. Table of contents. The table of contents must be identical to the headings and subheadings in the body of the manuscript and designated as I.A.1.a. The table of contents will not include 5th order or higher headings, but such headings may be usedin the body of the manuscript, if necessary.
5. Body of manuscript.
6. Acknowledgments. The Acknowledgments section is placed at the end of the text.
7. References. References are cited in the text by giving the first author's name (or the first and second if they are the only authors) and the year of publication (e.g., Ruth and Gehrig, 1929; McCarthy, 1952; or Kennedy et al., 1960). In the reference list, the references should be arranged alphabetically by author and notnumbered. The names of all authors should be given in the reference list. If reference is made to more than one publication by the same author(s) in the same year, suffixes (a, b, c, etc.) should be added to the year in the text citation and in the references list. Journal titles should be abbreviated as given in the abbreviation list linked to the online Instructions to Authors. References to personal communications, unpublished observations, and papers submitted forpublication are given in parentheses at the appropriate location in the text, not in the list of references. Only papers that have been officially accepted for publication may becited as "in press" in the reference list. The authors are responsible for the accuracy of the references. The format for journal article, chapter and book references is asfollows:
Griffiths RR, Bigelow GE and Liebson IA (1986) Human coffee drinking: Reinforcing and physical dependence producing effects of caffeine. J Pharmacol Exp Ther 239:416-425.
Chernow B and O'Brian JT (1984) Overview of catecholamines in selected endocrinesystems, in Norepinephrine (Ziegler MG and Lake CR eds) pp 439-449, Williams & Wilkins, Baltimore.
Tallarida RJ and Murray RB (1987) Manual of Pharmacologic Calculations with Computer Programs. Springer-Verlag, New York.
8. Footnotes. Footnotes should be listed on a separate page and presented in the following order:
a)The name and full address (with street address or P.O. box, andpostal code) of person to receive reprint requests.
b) Numbered footnotes, using superscript numbers, beginning with those (if any) to authors' names and listed in order of appearance.
9. Tables. Each table must be on a separate page. The tables are numbered consecutively with Arabic numerals, and designed to fit the column or page size of the journal. A brief descriptive title is provided at the top of each table. General statements about the table follow the title in paragraph form. Footnotes to tables arereferenced by italicized lower case superscript letters (a, b, c, etc.) and defined beneath the table.
10. Legends for figures. Figures are numbered consecutively with Arabic numerals, with each one displayed on a separate page. Legends must provide sufficient explanation for the reader to understand the figure independent of the text.
11. Figures. Submit illustrations as glossy photographs, original India-ink drawings, or high-resolution laser printer output. Lettering on figures should be large enough to be legible after reduction to single-column width of 21 picas (about 3-1/2 inches or 9 cm). Letter typesizes after reduction should be 6-8 points. Do not use varying letter typesizes within a single figure; use the same size or similar sizes throughout the drawing. Figures should be ready, in all respects, for direct reproduction. All panels of a multipart figure should be provided on the same page. Although each of the three manuscript copies should contain a complete set of figures, only the originals need be of the quality suitable for reproduction. In the case of halftones, three sets of photographs are required. If symbols are not explained on the face of the figure, only standard print characters may be used. The back of each figure should bear its number, the name of the first author, and the word TOP at the appropriate edge. The title of each figure is included in the legend, not on the figure itself. Photomicrographs and electron micrographs must be labeled with amagnification calibration in micrometers or Angstrom units. A statement concerning the magnification must appear in the figure legend.
The cost of publishing color figures will be billed to authors at a rate of $400 per figure. If the corresponding author is an ASPET member in good standing when the paper is published and the referees and editor agree that color is necessary to convey the desired information, then the rate is $200 per figure. Multiple-part figures submitted as separate illustrations are charged as separate figures.
Drugs
Generic drug names are used in text, tables and figures. Trade names may be given in parentheses following the first text reference, but should not appear in titles, figures, or tables. Whereas trade names are capitalized, generic or chemical names are not. The chemical structure of new compounds (or a citation to the published structure)must be given. The form used in calculating concentrations (e.g., base or salt) must be indicated.
Receptor Nomenclature
The nomenclature used to identify receptors and ion channels should conform to guidelines of the Committee on Receptor Nomenclature and Drug Classification of the International Union of Pharmacology. These are published periodically in Pharmacological Reviews.
After Acceptance
Authors must submit electronic diskettes of the final version of the manuscript along with the original and one copy of the printed manuscript. Although diskettes produced on IBM or IBM-compatible computers are preferred, those produced on most Apple/Macintosh or Wang computers are acceptable. The following word processingprograms are preferred: Microsoft Word (IBM or Macintosh), WordPerfect (IBM or Macintosh), and Wordstar (IBM). Authors preparing diskettes onMacintosh computers should not use the Fast Save option. Other formats and files in ASCII can be used, but are not encouraged. Identify the diskette by providing the journal name, manuscript number, first author's name, manuscript title, name of computer file, type ofhardware, operating system and version number, and software program and version number. Authors are encouraged to supply a digital copy of their illustrations. Digital illustrations should be on a separate diskette from the article's text. Specifications and a list of acceptable formats are available at http://cjs.cadmus.com/da/. Authors will be billed for substantial changes to page proofs, which must be returned within 48 hours after receipt. Authors of published reviews receive jointly 100 offprints free of charge.
Editorial Board
EDITOR
DARRELL R. ABERNETHY
Baltimore, Maryland
ASSOCIATE EDITORS
|
ARTHUR J. ATKINSON, JR.
Bethesda, Maryland |
MARK P. MATTSON
Baltimore, Maryland |
|
ERIC P. BRASS
Torrance, California |
STEFAN R. NAHORSKI
Leicester, United Kingdom |
|
ANNETTE C. DOLPHIN
London, United Kingdom |
OVE A. NEDERGAARD
Odense, Denmark |
|
WILLIAM E. EVANS
Memphis, Tennessee |
ERIC PARKER
Kenilworth, New Jersey |
|
ROSS FELDMAN
London, Canada |
RAYMOND RUDDON
New Brunswick, New Jersey |
|
DAVID FLOCKHART
Washington, DC |
THERESA SHAPIRO
Baltimore, Maryland |
|
BERTIL FREDHOLM
Stockholm, Sweden |
BURT SHARP
Memphis, Tennessee |
|
STEPHEN D. HALL
Indianapolis, Indiana |
SANG-GOO SHIN
Seoul, Korea |
|
PERRY V. HALUSHKA
Charleston, South Carolina |
DANIEL L. SIMMONS
Provo, Utah |
|
PAUL INSEL
La Jolla, California |
C. MICHAEL STEIN
Nashville, Tennessee |
|
RALPH E. KAUFFMAN
Kansas City, Missouri |
JOUKO TUOMISTO
Kuopio, Finland |
|
YOSHIHISA KURACHI
Kobe, Japan |
PER MAGNE UELAND
Bergen, Norway |
|
DAN L. LONGO
Baltimore, Maryland |
ANTON WELLSTEIN
Washington, DC |
|
CHARLES MARSDEN |
|
|
